Literature DB >> 18509621

Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpine.

Donna M Platt1, James K Rowlett, Roger D Spealman.   

Abstract

RATIONALE: The mGluR5 antagonist MPEP has effects that suggest potential as a pharmacotherapy for cocaine addiction. MPEP can attenuate self-administration of cocaine in animals; however, studies usually involved only acute treatment with MPEP and a single dose of self-administered cocaine. Cocaine addicts use varied amounts of cocaine over long periods of time, and an effective pharmacotherapy would almost certainly require more chronic treatment.
OBJECTIVES: The present study (1) compared the effects of repeated treatment with MPEP or the NMDA receptor antagonist dizocilpine on the reinforcing effects of a range of doses of cocaine and (2) determined the pharmacological specificity of the effects of the drugs in attenuating cocaine self-administration compared to food-reinforced behavior. An effective pharmacotherapy should selectively reduce cocaine self-administration.
MATERIALS AND METHODS: Groups of monkeys responded under a fixed-ratio schedule of i.v. cocaine self-administration or food-pellet delivery. The effects of daily treatment with MPEP and dizocilpine were determined under both the schedule of i.v. cocaine injection and food delivery.
RESULTS: Treatment with MPEP and dizocilpine significantly reduced cocaine self-administration, producing rightward and downward shifts in the ascending limb of the cocaine dose-response function. MPEP and dizocilpine selectively and significantly attenuated self-administration of a low reinforcing dose of cocaine compared to food without evidence of tolerance.
CONCLUSIONS: Both MPEP and dizocilpine functioned as partially surmountable antagonists of the reinforcing effects of cocaine. The similar effects of the two drugs raises the possibility that MPEP attenuated the reinforcing effects of cocaine, at least in part, via mGluR5-mediated inhibition of NMDA receptor activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18509621      PMCID: PMC2536745          DOI: 10.1007/s00213-008-1191-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  37 in total

1.  Colocalization of glutamate ionotropic receptor subunits in the human temporal neocortex.

Authors:  M C González-Albo; J DeFelipe
Journal:  Cereb Cortex       Date:  2000-06       Impact factor: 5.357

Review 2.  Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders.

Authors:  W P Spooren; F Gasparini; T E Salt; R Kuhn
Journal:  Trends Pharmacol Sci       Date:  2001-07       Impact factor: 14.819

3.  Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice.

Authors:  C Chiamulera; M P Epping-Jordan; A Zocchi; C Marcon; C Cottiny; S Tacconi; M Corsi; F Orzi; F Conquet
Journal:  Nat Neurosci       Date:  2001-09       Impact factor: 24.884

4.  Repeated self-administered cocaine "binges" in rats: effects on cocaine intake and withdrawal.

Authors:  N H Mutschler; H E Covington; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2001-03       Impact factor: 4.530

5.  Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.

Authors:  D M O'Leary; V Movsesyan; S Vicini; A I Faden
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

6.  Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.

Authors:  Paul M Lea; Vilen A Movsesyan; Alan I Faden
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

7.  Effects of the competitive N-methyl-D-aspartate receptor antagonist, LY235959 [(-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid], on responding for cocaine under both fixed and progressive ratio schedules of reinforcement.

Authors:  Richard M Allen; Regina M Carelli; Linda A Dykstra; Therese L Suchey; Carson V Everett
Journal:  J Pharmacol Exp Ther       Date:  2005-07-15       Impact factor: 4.030

8.  Attenuation of behavioral effects of cocaine by the Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine.

Authors:  Buyean Lee; Donna M Platt; James K Rowlett; Adepero S Adewale; Roger D Spealman
Journal:  J Pharmacol Exp Ther       Date:  2004-11-18       Impact factor: 4.030

9.  [3H]MK-801 binding and the mRNA for the NMDAR1 subunit of the NMDA receptor are differentially distributed in human and rat forebrain.

Authors:  P Meoni; M Mugnaini; B H Bunnemann; D G Trist; N G Bowery
Journal:  Brain Res Mol Brain Res       Date:  1998-02

Review 10.  Glutamate systems in cocaine addiction.

Authors:  Peter W Kalivas
Journal:  Curr Opin Pharmacol       Date:  2004-02       Impact factor: 5.547

View more
  38 in total

1.  mGlu receptors and drug addiction.

Authors:  Richard M Cleva; M Foster Olive
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-01-20

Review 2.  Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction.

Authors:  M Foster Olive
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

3.  Chronic cocaine exposure induces putamen glutamate and glutamine metabolite abnormalities in squirrel monkeys.

Authors:  Xiaoxu Liu; J Eric Jensen; Timothy E Gillis; Chun S Zuo; Andrew P Prescot; Melanie Brimson; Kenroy Cayetano; Perry F Renshaw; Marc J Kaufman
Journal:  Psychopharmacology (Berl)       Date:  2011-04-15       Impact factor: 4.530

4.  Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.

Authors:  Santosh S Kulkarni; Mu-Fa Zou; Jianjing Cao; Jeffrey R Deschamps; Alice L Rodriguez; P Jeffrey Conn; Amy Hauck Newman
Journal:  J Med Chem       Date:  2009-06-11       Impact factor: 7.446

Review 5.  Psychostimulant-induced neuroadaptations in nucleus accumbens AMPA receptor transmission.

Authors:  R Christopher Pierce; Marina E Wolf
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

6.  Antagonism of metabotropic glutamate 1 receptors attenuates behavioral effects of cocaine and methamphetamine in squirrel monkeys.

Authors:  Cindy Achat-Mendes; Donna M Platt; Roger D Spealman
Journal:  J Pharmacol Exp Ther       Date:  2012-07-18       Impact factor: 4.030

7.  3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure in rats.

Authors:  Andrew S Felts; Stacey R Lindsley; Jeffrey P Lamb; Alice L Rodriguez; Usha N Menon; Satyawan Jadhav; Carrie K Jones; P Jeffrey Conn; Craig W Lindsley; Kyle A Emmitte
Journal:  Bioorg Med Chem Lett       Date:  2010-06-15       Impact factor: 2.823

8.  Fenobam sulfate inhibits cocaine-taking and cocaine-seeking behavior in rats: implications for addiction treatment in humans.

Authors:  Thomas M Keck; Hong-Ju Yang; Guo-Hua Bi; Yong Huang; Hai-Ying Zhang; Ratika Srivastava; Eliot L Gardner; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Psychopharmacology (Berl)       Date:  2013-04-25       Impact factor: 4.530

9.  Operant sensation seeking requires metabotropic glutamate receptor 5 (mGluR5).

Authors:  Christopher M Olsen; Daniel S Childs; Gregg D Stanwood; Danny G Winder
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

10.  Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.

Authors:  Brittney S Bates; Alice L Rodriguez; Andrew S Felts; Ryan D Morrison; Daryl F Venable; Anna L Blobaum; Frank W Byers; Kera P Lawson; J Scott Daniels; Colleen M Niswender; Carrie K Jones; P Jeffrey Conn; Craig W Lindsley; Kyle A Emmitte
Journal:  Bioorg Med Chem Lett       Date:  2014-06-11       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.